Atlas Trials

Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis

Clinical trial NCT01022970 · COMPLETED

Trial details

NCT number
NCT01022970
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Eosinophilic Esophagitis
Start date
2009-11-01
Primary completion
2012-02-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.